RE:RE:RE:RE:RE:EU Legislative proposals aims to expedite new medicinesArticle: Pharma's pursuit of biotech innovations through M&A.
"The rapid pace of technological advancements, combined with the increasing demand for personalized (precision) medicine, is expected to drive further collaborations and M&A activity in the industry."
https://www.laboratoriosrubio.com/en/pharmas-biotech-ma/